Ezh2 and kdm6b expressions are associated with specific epigenetic signatures during emt in non small cell lung carcinomas

HIGHLIGHTS

• who: Camille Lachat and colleagues from the Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Université Rennes1, Rennes, France have published the research work: EZH2 and KDM6B Expressions Are Associated with Specific Epigenetic Signatures during EMT in Non Small Cell Lung Carcinomas, in the Journal: (JOURNAL)
• what: The authors evaluated the function of these two enzymes using an EMT-inducible model the lung cancer A549 cell line.
• how: The authors next decided to clarify the function of these enzymes during EMT using specific inhibitors of EZH2 and KDM6B (EZH2i GSK343 and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.